192 related articles for article (PubMed ID: 29296913)
21. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
[TBL] [Abstract][Full Text] [Related]
22. [Gray zone lymphoma: five cases report and literature review].
Zou HS; Zhang HJ; Liu HM; Huang WY; Liu W; Lyu R; Wang TY; Sui WW; Fu MW; Wang Q; Qiu LG; Zou DH
Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):242-246. PubMed ID: 37356987
[No Abstract] [Full Text] [Related]
23. Gray Zone Lymphoma: Current Diagnosis and Treatment Options.
Pilichowska M; Kritharis A; Evens AM
Hematol Oncol Clin North Am; 2016 Dec; 30(6):1251-1260. PubMed ID: 27888879
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
[TBL] [Abstract][Full Text] [Related]
26. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.
Iwaki N; Sato Y; Kurokawa T; Maeda Y; Ohno K; Takeuchi M; Takata K; Orita Y; Nakao S; Yoshino T
Med Mol Morphol; 2013 Sep; 46(3):172-6. PubMed ID: 23512149
[TBL] [Abstract][Full Text] [Related]
27. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z
Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma].
Liu SZ; Zong XP; Cai WZ; He HJ; Ma ZX; Li JQ; Li CX; Wu DP
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):69-73. PubMed ID: 38178771
[TBL] [Abstract][Full Text] [Related]
29. B Cell Lymphoma, Unclassifiable, Transformed from Follicular Lymphoma: A Rare Presentation with Review of the Literature.
Kanna A; Agrawal S; Jayant K; Kumar Pala V; Altujjar M; Hadid T; Khurram M
Case Rep Hematol; 2015; 2015():651764. PubMed ID: 26380128
[TBL] [Abstract][Full Text] [Related]
30. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site.
Cotta CV; Coleman JF; Li S; Hsi ED
Histopathology; 2011 Dec; 59(6):1194-203. PubMed ID: 22175899
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.
Wang S; Medeiros LJ; Xu-Monette ZY; Zhang S; O'Malley DP; Orazi A; Zuo Z; Bueso-Ramos CE; Yin CC; Liu Z; Miranda RN; Young KH
Ann Diagn Pathol; 2014 Aug; 18(4):203-9. PubMed ID: 24852241
[TBL] [Abstract][Full Text] [Related]
32. The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma.
Hao X; Wei X; Huang F; Wei Y; Zeng H; Xu L; Zhou Q; Feng R
PLoS One; 2015; 10(5):e0126615. PubMed ID: 25974110
[TBL] [Abstract][Full Text] [Related]
33. Pediatric gray zone lymphoma according to the 2022 WHO classification: An Italian cohort study.
Restivo GA; Farruggia P; Pillon M; Mascarin M; Elia C; Recupero S; Muggeo P; Cagnazzo C; Onofrillo D; Mura R; Furfari I; Trizzino A; Bertolini P; Sala A; De Santis R; Galimberti D; Schiavello E; Carraro E;
Pediatr Blood Cancer; 2023 May; ():e30481. PubMed ID: 37254478
[TBL] [Abstract][Full Text] [Related]
34. Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remission.
Terao T; Yuda J; Yamauchi N; Guo YM; Shimada K; Sugano M; Ishii G; Minami Y
Mol Clin Oncol; 2021 Jun; 14(6):125. PubMed ID: 33936598
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis.
Song CG; Huang JJ; Li YJ; Xia Y; Wang Y; Bi XW; Jiang WQ; Huang HQ; Lin TY; Li ZM
PLoS One; 2015; 10(7):e0133973. PubMed ID: 26222726
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of international prognostic indices in gray-zone lymphoma.
Witte HM; Merz H; Bernd HW; Bauer A; Bernard V; Feller AC; Gebauer N
Leuk Lymphoma; 2022 Apr; 63(4):894-902. PubMed ID: 34856873
[TBL] [Abstract][Full Text] [Related]
37. Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.
Molina TJ; Canioni D; Copie-Bergman C; Recher C; Brière J; Haioun C; Berger F; Fermé C; Copin MC; Casasnovas O; Thieblemont C; Petrella T; Leroy K; Salles G; Fabiani B; Morschauser F; Mounier N; Coiffier B; Jardin F; Gaulard P; Jais JP; Tilly H
J Clin Oncol; 2014 Dec; 32(35):3996-4003. PubMed ID: 25385729
[TBL] [Abstract][Full Text] [Related]
38. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G;
J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305
[TBL] [Abstract][Full Text] [Related]
39. Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.
O'Malley DP; Fedoriw Y; Weiss LM
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):535-40. PubMed ID: 26447896
[TBL] [Abstract][Full Text] [Related]
40. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
